Nam Hyo Suk, Lee Kyung-Yul, Han Sang Won, Kim Seo Hyun, Lee Jong Yun, Ahn Seong Hwan, Kim Dong Joon, Kim Dong Ik, Nam Chung Mo, Heo Ji Hoe
Department of Neurology and National Core Research Center for Nanomedical Technology, Yonsei University College of Medicine, Seoul, South Korea.
J Neurol Sci. 2009 Jun 15;281(1-2):69-73. doi: 10.1016/j.jns.2009.02.365. Epub 2009 Mar 21.
We investigated a method for assessing early improvement and predictive factors of early and late outcomes in patients receiving thrombolytic therapy.
A total of 160 consecutive patients who received thrombolytic therapy were included in the study. Using National Institutes of Health Stroke Scale (NIHSS) scores, percent improvement [(baseline NIHSS score-24-hour NIHSS score)/baseline NIHSS score x 100] was calculated and compared with delta (baseline NIHSS score-24-hour NIHSS score) and with major neurological improvement (MNI, NIHSS score of 0-1 or >or=8 point improvement at 24 h) by receiver operating characteristic (ROC) curve analysis. Finally, we investigated the independent predictors of improvement at 24 h after the thrombolytic therapy and of favorable 3-month outcome (modified Rankin scale score 0-2).
By pairwise comparison of ROC curves, percent improvement was stronger than delta (p=0.004) and MNI (p<0.001) in predicting long-term outcome. First day improvement (FDI), defined as greater than 20% improvement, was a strong predictor of favorable 3-month outcome (OR 12.55, 95% CI 5.41-29.10). Recanalization (OR 3.30, 95% CI 1.28-8.45), absence of carotid T occlusion (OR 0.09, 95% CI 0.02-0.42) and hemorrhagic transformation (OR 0.25, 95% CI 0.09-0.73) were independent predictors of FDI. Independent predictors of favorable 3-month outcome were FDI, current smoking, absence of carotid T occlusion and hemorrhagic transformation.
Percent improvement at 24 h after thrombolytic therapy is a useful surrogate marker for predicting the long-term outcome. Our findings highlight the importance of early stroke management.
我们研究了一种评估接受溶栓治疗患者早期改善情况以及早期和晚期预后预测因素的方法。
本研究纳入了160例连续接受溶栓治疗的患者。使用美国国立卫生研究院卒中量表(NIHSS)评分计算改善百分比[(基线NIHSS评分 - 24小时NIHSS评分)/基线NIHSS评分×100],并通过受试者工作特征(ROC)曲线分析与差值(基线NIHSS评分 - 24小时NIHSS评分)以及主要神经功能改善情况(MNI,24小时时NIHSS评分为0 - 1分或改善≥8分)进行比较。最后,我们研究了溶栓治疗后24小时改善情况以及3个月良好预后(改良Rankin量表评分为0 - 2分)的独立预测因素。
通过ROC曲线的两两比较,在预测长期预后方面,改善百分比比差值(p = 0.004)和MNI(p < 0.001)更强。首日改善(FDI)定义为改善超过20%,是3个月良好预后的有力预测因素(OR 12.55,95% CI 5.41 - 29.10)。再通(OR 3.30,95% CI 1.28 - 8.45)、无颈动脉T闭塞(OR 0.09,95% CI 0.02 - 0.42)和出血转化(OR 0.25,95% CI 0.09 - 0.73)是FDI的独立预测因素。3个月良好预后的独立预测因素为FDI、当前吸烟、无颈动脉T闭塞和出血转化。
溶栓治疗后24小时的改善百分比是预测长期预后的有用替代指标。我们的研究结果突出了早期卒中管理的重要性。